Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Peter Valent, Cem Akin, Dean D. Metcalfe
Blood (2016) Vol. 129, Iss. 11, pp. 1420-1427
Open Access | Times Cited: 614

Showing 1-25 of 614 citing articles:

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1200-1228
Open Access | Times Cited: 1634
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
Peter Valent, Cem Akin, Karin Hartmann, et al.
HemaSphere (2021) Vol. 5, Iss. 11, pp. e646-e646
Open Access | Times Cited: 204
Heritable risk for severe anaphylaxis associated with increased α-tryptase–encoding germline copy number at TPSAB1
Jonathan J. Lyons, Jack Chovanec, Michael P. O’Connell, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 147, Iss. 2, pp. 622-632
Closed Access | Times Cited: 170
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts
Peter Valent, Cem Akin, Karin Hartmann, et al.
Theranostics (2020) Vol. 10, Iss. 23, pp. 10743-10768
Open Access | Times Cited: 142
Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases
Pavel Kolkhir, Daniel Elieh Ali Komi, Martin Metz, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 5, pp. 294-308
Closed Access | Times Cited: 128
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
Jason Gotlib, Andreas Reiter, Deepti Radia, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2192-2199
Open Access | Times Cited: 103
Anaphylaxis: A 2023 practice parameter update
David B.K. Golden, Julie Wang, Susan Waserman, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 2, pp. 124-176
Open Access | Times Cited: 87
Mast cell activation syndromes
Cem Akin
Journal of Allergy and Clinical Immunology (2017) Vol. 140, Iss. 2, pp. 349-355
Closed Access | Times Cited: 160
Hereditary Alpha Tryptasemia
Jonathan J. Lyons
Immunology and Allergy Clinics of North America (2018) Vol. 38, Iss. 3, pp. 483-495
Open Access | Times Cited: 135
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Georg Greiner, Bettina Sprinzl, Aleksandra Górska, et al.
Blood (2020) Vol. 137, Iss. 2, pp. 238-247
Open Access | Times Cited: 135
Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers
Teodorikez Wilfox Jiménez‐Rodriguez, Marlene Garcia-Neuer, Leila A. Alenazy, et al.
Journal of Asthma and Allergy (2018) Vol. Volume 11, pp. 121-142
Open Access | Times Cited: 134
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
Peter Valent, Attilio Orazi, Michael R. Savona, et al.
Haematologica (2019) Vol. 104, Iss. 10, pp. 1935-1949
Open Access | Times Cited: 118
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
Wolfgang R. Sperr, Michael Kundi, Iván Álvarez‐Twöse, et al.
The Lancet Haematology (2019) Vol. 6, Iss. 12, pp. e638-e649
Open Access | Times Cited: 118
Mast Cells as Drivers of Disease and Therapeutic Targets
Frank Siebenhaar, Frank A. Redegeld, Stephan C. Bischoff, et al.
Trends in Immunology (2017) Vol. 39, Iss. 2, pp. 151-162
Open Access | Times Cited: 116
MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
Mohamad Jawhar, Juliana Schwaab, Iván Álvarez‐Twöse, et al.
Journal of Clinical Oncology (2019) Vol. 37, Iss. 31, pp. 2846-2856
Open Access | Times Cited: 103
Primary atopic disorders
Jonathan J. Lyons, Joshua D. Milner
The Journal of Experimental Medicine (2018) Vol. 215, Iss. 4, pp. 1009-1022
Open Access | Times Cited: 88
The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS)
Alison H. Kucharik, Christopher Chang
Clinical Reviews in Allergy & Immunology (2019) Vol. 58, Iss. 3, pp. 273-297
Closed Access | Times Cited: 82
Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical Trials
Takahito Kawano, Junichi Inokuchi, Masatoshi Eto, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1748-1748
Open Access | Times Cited: 74
Use and Interpretation of Acute and Baseline Tryptase in Perioperative Hypersensitivity and Anaphylaxis
Joana Vitte, Vito Sabato, Charles Tacquard, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 8, pp. 2994-3005
Open Access | Times Cited: 61
Hereditary alpha tryptasemia is not associated with specific clinical phenotypes
Madeleine B. Chollet, Cem Akin
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 2, pp. 728-735.e2
Closed Access | Times Cited: 59
Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis
Allyson Mateja, Qinlu Wang, Jack Chovanec, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 3, pp. 1010-1017.e10
Open Access | Times Cited: 56
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice
Peter Valent, Karin Hartmann, Juliana Schwaab, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1999-2012.e6
Open Access | Times Cited: 47
New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy
Peter Valent, Cem Akin, Wolfgang R. Sperr, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 361-386
Open Access | Times Cited: 40
Mast cell ontogeny: From fetal development to life‐long health and disease
Shin Li Chia, Simran S. Kapoor, Cyril Carvalho, et al.
Immunological Reviews (2023) Vol. 315, Iss. 1, pp. 31-53
Open Access | Times Cited: 33
Avapritinib versus Placebo in Indolent Systemic Mastocytosis
Jason Gotlib, Mariana Castells, Hanneke Oude Elberink, et al.
NEJM Evidence (2023) Vol. 2, Iss. 6
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top